Skip to content
PubMed This is a summary of 46 peer-reviewed journal articles Updated
Medical Genetics

Cardiofaciocutaneous Syndrome 3 (CFC3): A Patient Guide

At a Glance

Cardiofaciocutaneous syndrome 3 is a rare genetic condition caused by a MAP2K1 gene change that can affect the heart, brain, skin, digestion, feeding, growth, and development. Early screening, nutrition support, therapies, and coordinated specialist care help address each child's needs.

Disclaimer: This guide provides educational information and does not replace the advice of your child’s medical team. Always call your local emergency number for immediate life-threatening symptoms.

Cardiofaciocutaneous Syndrome 3 (CFC3) is a rare genetic condition that affects many of the body’s systems, including the heart, brain, skin, and digestive tract. It belongs to a group of conditions known as RASopathies, which occur when a specific biological pathway used for cell growth and division—the RAS/MAPK pathway—becomes overactive [1]. In CFC3, this overactivity is caused by a change, or mutation, in the MAP2K1 gene, which provides instructions for a protein called MEK1 [2]. Because this pathway is essential for development before and after birth, its constant “on” signal leads to the physical and developmental features that characterize the syndrome [3].

The condition is multisystem in nature, meaning it can influence health in diverse ways. Note that much of the medical data comes from studies looking at all types of CFC combined, so severity and symptoms for an individual child with a MAP2K1 mutation can vary widely. Many children with CFC experience heart findings, such as a narrowing of the heart valves or a thickening of the heart muscle, and these conditions can sometimes change as a child grows [4]. Neurologically, the syndrome often involves low muscle tone, developmental delays, and a risk of seizures, which may require targeted monitoring from a neurologist [5]. Additionally, distinctive physical features involving the skin and hair—such as very curly hair or rough, bumpy skin—are common signatures of how the MAP2K1 mutation affects the body’s outer layers [3].

One of the most immediate and impactful aspects of living with CFC involves feeding and nutrition. The vast majority of children with this diagnosis face challenges with sucking, swallowing, or severe reflux, which can make gaining weight difficult [6]. These issues are a biological part of the syndrome and often require a proactive approach, including the help of feeding therapists and, in many cases, the use of feeding tubes to ensure the child receives the hydration and calories they need to thrive [7]. Managing these nutritional needs is a cornerstone of care that supports the child’s overall growth and energy levels.

Because CFC3 affects so many areas of health, the most effective way to manage the condition is through a dedicated team of specialists. This team typically includes experts in genetics, cardiology, neurology, early intervention therapies, and gastroenterology, all working together to monitor your child’s progress and address symptoms early [8]. While the diagnosis brings complex challenges, the focus of modern care is on empowering families through early screening and personalized support. With consistent monitoring and a coordinated care plan, children with CFC3 can be supported in reaching their unique developmental milestones and maintaining the highest possible quality of life [4].

Common questions in this guide

What causes cardiofaciocutaneous syndrome 3?
CFC3 is caused by a change in the MAP2K1 gene. This change can keep the RAS/MAPK pathway, which helps control cell growth and development, too active, leading to features that affect several body systems.
What health problems can a child with CFC3 have?
CFC3 can affect the heart, brain, skin, hair, digestive system, feeding, growth, and development. Possible concerns include heart valve narrowing or thickened heart muscle, low muscle tone, developmental delays, seizure risk, distinctive hair or skin, reflux, swallowing difficulty, and poor weight gain. Symptoms and severity vary widely.
Why are feeding and nutrition support so important in CFC3?
Many children have difficulty sucking or swallowing, or severe reflux, which can make it hard to get enough calories and fluids or gain weight. Feeding therapists can help, and some children need a feeding tube for reliable hydration and nutrition. The child's care team should monitor growth and adjust support.
Which specialists should care for a child with CFC3?
Care often involves a coordinated team that may include medical genetics, cardiology, neurology, gastroenterology, feeding or early-intervention therapists, and the child's primary clinician. One clinician can help coordinate visits, testing, and follow-up across specialties. The exact team depends on the child's symptoms and needs.
What screening and monitoring does a child with CFC3 need?
The medical team may recommend baseline and ongoing assessments of the heart, neurologic development, growth and nutrition, and developmental progress. Vision and hearing checks may also be considered as part of the child's overall evaluation. Timing and urgency should be individualized by the child's clinicians.
How does CFC3 affect a child's long-term outlook?
The outlook varies widely because children with MAP2K1 changes can have different combinations and severity of health and developmental concerns. Early screening, coordinated care, therapies, and nutrition support can help the team address problems promptly and support each child's milestones and quality of life. The genetics and medical teams can discuss how a child's specific change may affect their outlook.

Get notified when new evidence is published on cardiofaciocutaneous syndrome 3.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (8)
  1. 1

    Case report: The cardio-facio-cutaneous syndrome due to a novel germline mutation in MAP2K1: A multifaceted disease with immunodeficiency and short stature.

    Szczawińska-Popłonyk A, Popłonyk N, Niedziela M, et al.

    Frontiers in pediatrics 2022; (10()):990111 doi:10.3389/fped.2022.990111.

    PMID: 36313893
  2. 2

    Phoniatric, Audiological, Orodental and Speech Problems in a Boy with Cardio-Facio-Cutaneous Syndrome Type 3 (CFC 3) Due to a Pathogenic Variant in MAP2K1 - Case Study.

    Kosztyła-Hojna B, Borys J, Zdrojkowski M, et al.

    The application of clinical genetics 2021; (14()):389-398 doi:10.2147/TACG.S316215.

    PMID: 34522120
  3. 3

    Cardio-facio-cutaneous syndrome-associated pathogenic MAP2K1 variants activate autophagy.

    Chen J, Che L, Xu C, et al.

    Gene 2020; (733()):144369 doi:10.1016/j.gene.2020.144369.

    PMID: 31972311
  4. 4

    Cardiac Manifestations and Associations with Gene Mutations in Patients Diagnosed with RASopathies.

    Jhang WK, Choi JH, Lee BH, et al.

    Pediatric cardiology 2016; (37(8)):1539-1547 doi:10.1007/s00246-016-1468-6.

    PMID: 27554254
  5. 5

    Neurologic and neurodevelopmental complications in cardiofaciocutaneous syndrome are associated with genotype: A multinational cohort study.

    Pierpont EI, Kenney-Jung DL, Shanley R, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2022; (24(7)):1556-1566 doi:10.1016/j.gim.2022.04.004.

    PMID: 35524774
  6. 6

    Management of nutritional and gastrointestinal issues in RASopathies: A narrative review.

    Onesimo R, Giorgio V, Viscogliosi G, et al.

    American journal of medical genetics. Part C, Seminars in medical genetics 2022; (190(4)):478-493 doi:10.1002/ajmg.c.32019.

    PMID: 36515923
  7. 7

    The "FEEDS (FEeding Eating Deglutition Skills)" over Time Study in Cardiofaciocutaneous Syndrome.

    Onesimo R, Sforza E, Giorgio V, et al.

    Genes 2023; (14(7)) doi:10.3390/genes14071338.

    PMID: 37510243
  8. 8

    RASopathies: Dermatologists' viewpoints.

    Palit A, Inamadar AC

    Indian journal of dermatology, venereology and leprology 2022; (88(4)):452-463.

    PMID: 35138057

This CFC3 guide is for informational purposes only and does not constitute medical advice or replace your child's medical team. Contact local emergency services for life-threatening symptoms, and ask your clinicians about individualized screening, feeding support, and treatment.